Clinical Trial
Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine
- PMID: 4891707
Item in Clipboard
Clinical Trial
Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine
Ann Allergy.
1969 Jun.
No abstract available
Similar articles
-
The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.Ann Med Intern Fenn. 1968;57(1):31-5. Ann Med Intern Fenn. 1968. PMID: 4882181 Clinical Trial. No abstract available.
-
Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019).Ann Med Exp Biol Fenn. 1969;47(4):298-302. Ann Med Exp Biol Fenn. 1969. PMID: 4911261 Clinical Trial. No abstract available.
-
Objective assessment of a bronchodilator drug combination in asthmatic outpatients.Curr Ther Res Clin Exp. 1973 Jun;15(6):273-84. Curr Ther Res Clin Exp. 1973. PMID: 4197251 Clinical Trial. No abstract available.
-
[Pathological anatomy in heart insufficiency].Arztl Forsch. 1967 Feb 10;21(2):41-50. Arztl Forsch. 1967. PMID: 4873357 Review. German. No abstract available.
-
On the action of combination bronchodilators.Agents Actions. 1979 Oct;9(4):301-9. doi: 10.1007/BF01970652. Agents Actions. 1979. PMID: 391006 Review. No abstract available.